Abstract:Purpose: The appearance of pulmonary metastases in neoplastic patients previously submitted to radical operation of an extrapulmonary primary tumor and with no recurrences and/or secondary distant localizations can markedly worsen disease prognosis if the lesions are in advanced stages and no longer removable by surgical procedures. In this study, we evaluated the usefulness of 99mTc-tetrofosmin scintigraphy, both planar and SPECT, in the detection of pulmonary metastases from previously treated extrapulmonary primary tumors, comparing the results with those obtained with CT. Materials and methods: We studied 73 patients, 33 M and 40 F, aged 24 to 79 yrs, had who undergone previously surgical resection extrapulmonary primary tumors; 31 patients had mammary, 13 gastrointestinal, 13 genitourinary, 13 thyroid and 3 laryngeal carcinomas. In all patients CT ascertained single (42 cases) or multiple (31 cases) pulmonary lesions. 99mTc-tetrofosmin scintigraphy, always performed within a week of CT, was acquired 10 min after 740 MBq i.v. tracer injection, using a rectangular, large field of view, dual head gamma camera, equipped with low energy, parallel-hole and high resolution collimators. Conventional planar acquisition, with the patient in the supine position, was followed by SPECT over 360 degrees with body contouring system, using a zoom factor of 1-1.3, a 64x64 matrix size, a 3 degrees angular step and an acquisition time of 30 sec/frame; image reconstruction was performed with the Back Projection Filtered Method using a Metz filter. In the coronal slices of SPECT images a semiquantitative analysis of the lesion was also made and the tumor-to-background (T/B) ratio was calculated; the calculation of the latter, considered indicative for tumor when >1.4, was performed in the lesion with the highest radiotracer uptake in patients with multiple lung lesions. The results of SPECT qualitative images were compared with those of planar scintigraphy and both of these with the data obtained with CT, and statistical difference was calculated with McNemar's test. The definitive diagnosis was achieved after scintigraphy by the analysis of cytologic or histologic specimens obtained by thoracotomy, percutaneous thoracic needle biopsy or bronchoscopic biopsy, and in some cases by the confirmation of instrumental exams at 6-8 month follow up. Pulmonary metastases were ascertained in 65/73 cases, while benign lesions were present in the remaining 8 patients. Results: CT was true positive in 60/65 (92.3%) patients with metastases and false negative in the remaining five, four with a single lesion and one with two lesions in the same lung. SPECT detected metastases in 62/65 (95.4%) patients, including the five CT false negative cases, while it was false negative in three cases with single lesions, all positive at CT, with a size of 1.0, 1.0, 2.0 cm, respectively. Planar scintigraphy was only positive in 23/65 (35.4%) patients, with a sensitivity value significantly (p<0.0005) lower than both SPECT and CT. In the patients with multiple metastases, SPECT, positive in all cases and capable of correctly differentiating the patients with metastases only in one lung from those with bilateral involvement, underestimated the number of micronodular lesions in respect of CT in six patients with >6 lesions < or =0.5 cm in size, while it was more sensitive in three other cases; CT and SPECT were concordant in macronodular metastases detection, except in one case in which SPECT depicted more lesions. Planar scintigraphy had 42 false negative results and, when positive, underestimated the number of multiple lesions in respect of both SPECT and CT; it was positive but CT negative in only one case with two lesions. Specificity was higher for both SPECT and planar scan (87.5%) than CT (62.5%) but not significantly; accuracy was higher for SPECT (94.5%) than both planar scan (42%) and CT (89%), but the difference was significant only in respect of planar. The combined use of SPECT and CT achieved 100% sensitivity and accuracy values. The T/B ratio was >1.ratio was >1.4 in all SPECT positive cases (range: 1.6-5.3), indicating a suspected tumor, while it was 1.2 in the only benign case which turned out to be false positive at qualitative SPECT imaging. Conclusions: 99mTc-tetrofosmin SPECT seems to be a reliable diagnostic tool in the detection of pulmonary metastases from extrapulmonary primary tumors, in particular in the cases in which CT is indeterminate or false positive, and therefore contributes to a more correct patient classification. Moreover, SPECT image semiquantitative analysis can give additional information for a differential diagnosis between malignant and benign lesions as well as offering a more accurate selection of the lesions to be subjected to biopsy in patients with multiple metastases. However, only the combined use of CT and 99mTc-tetrofosmin SPECT can achieve the highest sensitivity and accuracy values and obtain the correct staging in most patients, thus suggesting that these two procedures must be employed together.

Clinical value of 99 Tc m -octreotide SPECT/CT in diagnostics of lung cancer

Integrin Receptor Imaging 99Mtc-3Prgd2 SPECT/CT in Diagnosis and Lymph Node Staging of Non-Small Cell Lung Cancer

Evaluation of Standard Uptake Value of 99Mtc-3Prgd2 Spect/Ct in Lung Cancer Diagnosis

Pilot Study on the Value of ~(99m) Tc-HL91 SPECT Hypoxia Imaging in Diagnosis of Patients with Nasopharyngeal Carcinoma

The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors

Evaluation of the factors affecting the maximum standardized uptake value of metastatic lymph nodes in different histological types of non-small cell lung cancer on PET-CT

18F-FDG Imaging by Coincidence Circuit SPECT with Low-Dose CT in Preoperative Assessment of Pulmonary Lesions

The Advantage of PET and CT Integration in Examination of Lung Tumors

The clinical value of serum tumor markers combined PET/CT diagnosis on non-small cell lung cancer

The Clinical Value of ~(99)Tc~m-Hl91 Hypoxia Imaging Combined with the Detection of Serum NSE,CEA and CYFRA21-1 in the Diagnosis of Lung Cancer

Comparison of (11)C-choline PET/CT and enhanced CT in the evaluation of patients with pulmonary abnormalities and locoregional lymph node involvement in lung cancer

Prospective study of dual-phase 99mTc-MIBI SPECT/CT nomogram for differentiating non-small cell lung cancer from benign pulmonary lesions

The Added Diagnostic Value of SPECT/CT Imaging for Bone Metastases from Lung Cancer

Clinical value of 99mTc-PSMA SPECT/CT in detection of prostate cancer

Diagnostic Value Of Tc-99m-Mdp Spect/Spiral Ct Combined With Three-Phase Bone Scintigraphy In Assessing Suspected Bone Tumors In Patients With No Malignant History

[Application of ¹⁸F-FDG PET/CT in pulmonary disease: a report of 419 cases].

[Value of (18)F-Fluorodeoxyglucose Positron Emission Tomography/computed Tomography in Early Diagnosis of Lung Cancer].

Clinical Application of 99Mtc-Hynic-toc SPECT/CT in Diagnosing and Monitoring of Pancreatic Neuroendocrine Neoplasms

Analysis of SPECT/CT Fusion Imaging of Bone Metastases in Patients with Lung Cancer

Comparison Of Positron Emission Tomography Using 2-[F-18]-Fluoro-2-Deoxy-D-Glucose And 3-Deoxy-3-[F-18]-Fluorothymidine In Lung Cancer Imaging

Evaluation of 99Mtc-Hydrazinonicotinamide-tyr3-octreotide SPECT/CT in Detection of Liver Metastases in Patients with Neuroendocrine Tumors